Biotech Startups

Endolith develops biological intelligence technology for mineral recovery, using microbiology and AI to extract critical minerals sustainably. The company serves mining operations and the clean energy supply chain.

5 investors

Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases. The company applies pharmaceutical-industry drug discovery methods to agriculture, enabling faster development of new active ingredients with reduced environmental impact.

5 investors

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases. The company combines RNA biology expertise with machine learning to advance precision medicines.

5 investors

Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.

5 investors

EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.

5 investors

Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.

5 investors

FA Bio (formerly FungiAlert) discovers unique soil microbes to develop microbial-based biocontrol and biostimulant products for growers, aiming to replace agrochemicals and reduce farming's environmental impact. The company, spun out of Imperial College London, uses its SporSenZ technology for soil microbial analysis in the agri-tech sector.

5 investors

Feel Therapeutics develops digital biomarkers and digital health solutions for mental health treatment, designed to function as standalone programs or alongside medications. The company operates within the digital precision medicine space and partners with pharmaceutical and biotech firms on clinical development and commercialization.

5 investors

Ferronova develops magnetic iron-oxide nanoparticle tracers (FerroTrace) and related imaging and therapy technologies to detect and map lymph nodes and tumours in early-stage cancers, supporting surgeons, oncologists and pathologists in staging and treating cancers such as oral, colorectal, esophageal, prostate and pancreatic. Spun out from the University of South Australia and Victoria University, the company is based in Australia.

5 investors

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

5 investors

Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke. The device uses a dissolving polymer scaffold to promote blood vessel healing and simplify non-invasive follow-up imaging, and is currently limited to authorized clinical investigations.

5 investors

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.

5 investors

Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.

5 investors

Frontier Bio develops tissue engineering and bioprinting technology, including fabrication of tissue-engineered blood vessels for clinical and in vitro applications. The company works at the intersection of biology and engineering in the biotech and medical device space.

5 investors

Frontier is a drug discovery company developing small-molecule covalent drugs aimed at previously undruggable protein targets across the proteome. It uses a platform that maps druggable sites to generate a pipeline of novel therapeutic leads.

5 investors

General Control is developing programmable, multiplexed epigenetic editing therapies designed to control the expression of several genes at once. It targets complex diseases with many interacting phenotypes, such as Alzheimer's and sarcopenia.

5 investors

Generare is building a library of naturally evolved molecules by reading and analyzing biological chemistry that has not been previously studied.

5 investors

GlycanAge offers an at-home biological age test that analyzes IgG glycan patterns to measure chronic inflammation ("inflammaging") and its effect on aging. Customers use a finger-prick kit, receive a report on their glycan indexes and biological age, and get a 1:1 interpretation call with a specialist.

5 investors

Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.

5 investors

Green Earth Institute is a Japanese company operating a corporate office in Tokyo and a research center in Kisarazu, Chiba. The available page content only lists office and research center locations with access directions, giving limited detail on the company's business.

5 investors

GreenLight Biosciences develops RNA-based solutions for agriculture and pest control, including a Colorado potato beetle bio-insecticide and a Varroa destructor mite-control product for sustainable food production.

5 investors

Groundwork BioAg makes Rootella, a mycorrhizal soil inoculant that farmers apply to their fields, and runs the Rootella Carbon Program that lets growers earn carbon-credit income while improving soil health. It targets agricultural growers, distributing up to 70% of net carbon-credit proceeds to a farmer pool.

5 investors

Healx is an AI-powered biotech company that discovers and develops treatments for rare diseases. It applies artificial intelligence to accelerate rare disease drug discovery, and is based in the Cambridge area of the UK.

5 investors

Helaina uses precision fermentation to produce human proteins, including lactoferrin and other bioactive nutrients found in human milk, for consumer nutrition products serving athletes, new parents, and health-conscious consumers.

5 investors